Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1. Shimamoto K, Ohno S, Kato K, Takayama K, et al. Heart 2022;108:840-847.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shimamoto K, Ohno S, Kato K, Takayama K, et al. Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1. Heart 2022;108:840-847.
PMID: 35135837